Earlier this year, my colleague Matt Harrington suggested that clinical leaders should stop asking whether their organizations have an “AI strategy”, not because strategy doesn’t matter, but because the question often pr
Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment
The FDA has approved Merck's internally developed cholesterol-lowering treatment Lipfendra for adults with hypercholesterolemia, or high levels of "bad" cholesterol. The drug, which is the first oral PCSK9 inhibitor to r
Lark Health, Samsung team up on AI-powered health coach for U.S. seniors
Eligible seniors will be able to use one or more of Lark’s 12 chronic disease management and prevention programs with no out-of-pocket costs through Samsung Health.